Black Diamond Therapeutics Inc logo

BDTX - Black Diamond Therapeutics Inc News Story

$24.33 0.2  0.7%

Last Trade - 20/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £624.4m
Enterprise Value £399.1m
Revenue £n/a
Position in Universe 2952nd / 6849

BRIEF-Black Diamond Therapeutics Reports Q3 Loss Per Share Of $0.50

Tue 10th November, 2020 12:58pm
Nov 10 (Reuters) - Black Diamond Therapeutics Inc  BDTX.O :
    * BLACK DIAMOND THERAPEUTICS REPORTS THIRD QUARTER 2020
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * BLACK DIAMOND THERAPEUTICS - CASH, CASH EQUIVALENTS,
INVESTMENTS
OF $333.1 MILLION AS OF SEPT 30, EXPECTED TO BE SUFFICIENT TO
FUND OPERATIONS INTO 2023
    * QTRLY LOSS PER SHARE $0.50
    * Q3 EARNINGS PER SHARE VIEW $-0.52 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5xD60v 
Further company coverage:  BDTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.